Clinical Trial Update: Immunogenicity and Safety of Trivalent Influenza Vaccine in Non-pregnant HIV-infected Women [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluated the immunogenicity and safety of a trivalent influenza vaccine in non-pregnant women with HIV infection; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Trivalent influenza vaccine (Influenza vaccine, trivalent)

Snippet

Sponsor: University of Witwatersrand, South Africa | Conditions: Influenza, Human Immunodeficiency Virus | Phase 4 | Status: COMPLETED